.jpg?format=webp&width=780)
This study compared standard 6-month treatment for tuberculosis with a new strategy involving an initial 8-week treatment, extended treatment for persistent disease, monitoring, and retreatment for relapse. The new strategy involved different initial regimens, and noninferiority was assessed in two groups with complete enrollment. The primary outcome was a composite of death, ongoing treatment, or active disease at week 96. The study found that the strategy involving an initial treatment with an 8-week bedaquiline-linezolid regimen was non-inferior to standard treatment with respect to clinical outcomes, and it was associated with a shorter total duration of treatment and no evident safety concerns.
Like
Save
Share